Fate Therapeutics
Price & Volume
Stats
See more52W Range | $0.66-$4.20 |
Market Cap | $125.7M |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $8.4M |
Revenue Growth (YoY) | -71.8% |
Gross Profit (12 Mos) | -$106.8M |
Diluted EPS | -$1.46 |
News
See moreYahoo Finance • 2 days ago
Fate Therapeutics’ SWOT analysis: biotech stock navigates clinical progress amid financial challenges
Yahoo Finance • 4 days ago
FATE THERAPEUTICS INC (NASDAQ:FATE) Reports Mixed Q2 2025 Results with Revenue Beat and Narrower Loss
Yahoo Finance • 4 days ago
Fate Therapeutics Reports Second Quarter 2025 Financial Results and Business Updates
Yahoo Finance • 11 days ago
Fate Therapeutics CEO Valamehr sells $15,396 in stock
About
CEO | Dr. Bahram Valamehr M.B.A., Ph.D. |
Address | 12278 Scripps Summit Drive, San Diego, CA, United States, 92131 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 181 |
